Ofrecemos consultoría especializada que genera valor mediante soluciones innovadoras y tecnológicas en áreas regulatorias, farmacoeconómicas, economía de la salud, acceso al mercado y marketing.

Weber potencia más de 20 años de experiencia consolidada en el mercado

Últimas noticias:

WEBER leaves the Vivactis Group in line with the short-term strategy and reorganization process the Belgian holding company is implementing. 1630 326 Weber

WEBER leaves the Vivactis Group in line with the short-term strategy and reorganization process the Belgian holding company is implementing.

WEBER leaves the Vivactis Group in line with the short-term strategy and reorganization process the Belgian holding company is implementing. Madrid, the 3rd of July 2024 – At the end of June 2024, the VIVACTIS Group has decided to sell its entire stake in WEBER to Álvaro Hidalgo, one of its founders, as part of…

leer más
One Health Summit 2023 768 432 Weber

One Health Summit 2023

Bamberg Health organizes this One Health Summit in Brussels. The interconnection between environment, energy, animal health, public health, epidemiology, vaccination, agriculture, fisheries, livestock production, and food safety is crucial to understanding the concept of «One Health» and «Global Health. The Summit is structured in five thematic blocks: • One Health & Global Health • Environmental Health…

leer más
ITALY HEALTHCARE INNOVATION SUMMIT 2023 768 432 Weber

ITALY HEALTHCARE INNOVATION SUMMIT 2023

The healthcare industry in Italy is facing a digital revolution and it is necessary to understand how to use new data and technological solutions to improve medical, clinical and administrative workflows. That’s why we’re proud to present the Italian Healthcare Innovation Summit, where key players in the field will come together to discuss and explore…

leer más

Últimas publicaciones

Recommendations for effective patient involvement in the assessment of medical devices

El Valor Social de un mejor control de la obesidad en España

The assessment and funding processes of drugs in Spain and other OECD countries: Where are we and where are we going?